Results 31 to 40 of about 54,610 (286)

Anaesthetic Management of a Patient with Dilated Cardiomyopathy and Acute Decompensated Heart Failure [PDF]

Journal of Clinical and Diagnostic Research, 2022
Dilated Cardiomyopathy (DCM) is a non ischaemic heart muscle disease with left or biventricular dilatation and systolic dysfunction in the absence of other heart diseases.
Nitu Yadav, Bharti Verma, Priyanka Aggarwal, Rahul, Joseph Deeven Kranthikar Chiluka   +4 more
doaj   +1 more source

Renal function, electrolytes, and congestion monitoring in heart failure. [PDF]

, 2019
Congestion, renal function, and electrolyte imbalance (particularly potassium) are common problems in the management of the complex multi-morbid patient with heart failure (HF).
Chioncel, O, Coats, AJ, Rosano, G, Rossignol, P, Spoletini, I   +4 more
core   +3 more sources

Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? [PDF]

, 2018
Aims: Changes in systolic blood pressure (SBP) during an admission for acute heart failure (AHF), especially those leading to hypotension, have been suggested to increase the risk for adverse outcomes.
Bourge, Robert C., Cleland, John G.F., Cotter, Gad, Davison, Beth A., Edwards, Christopher, Jondeau, Guillaume, Kobrin, Isaac, McMurray, John J.V., Metra, Marco, Milo, Olga, O'Connor, Christopher M., Parker, John D., Rainisio, Maurizio, Senger, Stefanie, Teerlink, John R., Torre-Amione, Guillermo, van Veldhuisen, Dirk J.   +16 more
core   +5 more sources

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction

Clinical Case Reports, 2023
Ivabradine is an established treatment for chronic heart failure with reduced ejection fraction (HFrEF); however, it is not used for acute heart failure treatment. Negative inotropic effects (NIE) often limit the up‐titration of β‐blockers.
Tomoko Inoue, Keiji Matsunaga, Waki Kobayashi, Tetsuo Minamino   +3 more
doaj   +1 more source

Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Malnutrition is one of the most important comorbidities in patients with heart failure with preserved ejection fraction. We recently reported the prognostic significance of serum cholinesterase level and superior predictive power of ...
Masahiro Seo, Takahisa Yamada, Shunsuke Tamaki, Shungo Hikoso, Yoshio Yasumura, Yoshiharu Higuchi, Yusuke Nakagawa, Masaaki Uematsu, Haruhiko Abe, Hisakazu Fuji, Toshiaki Mano, Daisaku Nakatani, Masatake Fukunami, Yasushi Sakata   +13 more
doaj   +1 more source

Association between early intensive care or coronary care unit admission and post-discharge performance of activities of daily living in patients with acute decompensated heart failure.

PLoS ONE, 2021
The management of acute decompensated heart failure often requires intensive care. However, the effects of early intensive care unit/coronary care unit admission on activities of daily living (ADL) in acute decompensated heart failure patients have not ...
Masato Kanda, Kazuya Tateishi, Atsushi Nakagomi, Togo Iwahana, Sho Okada, Hiroyo Kuwabara, Yoshio Kobayashi, Takahiro Inoue   +7 more
doaj   +1 more source

Acute decompensated heart failure is routinely treated as a cardiopulmonary syndrome. [PDF]

PLoS ONE, 2013
Heart failure as recognized and treated in typical practice may represent a complex condition that defies discrete categorizations. To illuminate this complexity, we examined treatment strategies for patients hospitalized and treated for decompensated ...
Kumar Dharmarajan, Kelly M Strait, Tara Lagu, Peter K Lindenauer, Mary E Tinetti, Joanne Lynn, Shu-Xia Li, Harlan M Krumholz   +7 more
doaj   +1 more source

Improving Postdischarge Outcomes in Acute Heart Failure [PDF]

, 2018
The global burden that acute heart failure (AHF) carries has remained unchanged over the past several decades (1). European registries (2–5) showed that 1-year outcome rates remain unacceptably high (Table 1) and confirm that hospitalization for AHF ...
Ambrosy, Andrew P., Antohi, Elena-Laura, Butler, Javed, Chioncel, Ovidiu, Collins, Sean P., Iliescu, Vlad Anton, Maggioni, Aldo P., Mebazaa, Alexandre, Pang, Peter S.   +8 more
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy

Frontiers in Pediatrics, 2021
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor.
Shih-Hsing Lo, Yi-Ching Liu, Zen-Kong Dai, Zen-Kong Dai, I-Chen Chen, I-Chen Chen, Yen-Hsien Wu, Jong-Hau Hsu, Jong-Hau Hsu   +8 more
doaj   +1 more source